Subtle Medical and Bayer Have Partneres To Develop Deep Learning Research In Order To Harness The Power Of AI In Medical Imaging
Subtle Medical, a leading healthcare technology company, and Bayer, a leading life science company with extensive expertise from diagnosis to care, announced today a collaboration to explore opportunities to utilize AI (artificial intelligence) to aid in image acquisition in radiology. The companies will investigate the potential of Subtle Medical’s state-of-the-art AI algorithm, SubtleGAD, for use in contrast-enhanced MRI exams to enhance image quality and will explore potential new areas for contrast media use.
“At Bayer, we are constantly striving to advance medical knowledge and provide the best possible therapeutic and diagnostic options for physicians and patients…We are pleased to collaborate with Subtle Medical to harness the power of AI, with the ultimate goal of providing physicians with the means for optimal diagnosis for their patients.”
said Prof. Dr. Olaf Weber, Head of Radiology Research and Development at Bayer.
MRI tests allow doctors to get detailed images of the body and answer important medical concerns during disease diagnosis and monitoring. The demand for medical imaging to aid diagnosis, treatment decisions, and therapy planning has increased as the population ages. Artificial intelligence is a promising tool for assisting radiologists in providing correct and rapid diagnoses to their patients, as well as providing opportunities to reduce imaging exam times and dose. Subtle Medical’s deep learning algorithms, in particular, aid in the acquisition of higher quality images from both rapid and low dosage scans. Both firms are excited to work together to advance medical imaging innovation.
“We are proud to collaborate with Bayer to combine our expertise and drive innovative solutions in light of the ever increasing demands of medical imaging…At Subtle Medical, we are committed to continued innovation and the development of AI tools that create a meaningful impact for both radiologists and patients.”said Dr Ajit Shankaranarayanan, Chief Product Officer at Subtle Medical
“Bayer is a key partner due to their clinical expertise and proven track record in medical imaging. Such collaborations across the industry will be crucial to unlock the power of AI, ultimately benefiting patients, improving imaging capabilities and patient diagnosis worldwide,”
said Josh Gurewitz, Chief Commercial Officer at Subtle Medical.
Clinically certified AI-powered software solutions from Subtle Medical improve the quality of rapid and low dosage imaging while increasing picture capturing efficiency. Subtle’s solutions work with all scanner brands, models, and field strengths, allowing institutions to benefit from their entire scanner fleet. At RSNA 2021, meet with Subtle Medical.